Excess morbidity in klinefelter syndrome


Professor Michael Zitzman – also from CeRA, focusses on the increased morbidity and mortality evident in patients with Klinefelter syndrome. He discusses the reasons for this phenomenon, and presents evidence demonstrating the benefits of appropriate preventative treatment.



Dr. Michael Zitzmann

Prof. Dr. Michael Zitzmann
Fellow of the Royal Society of Medicine
Andrologist, Endocrinologist, Diabetologist
Specialist for Sexual Medicine (FECSM)
Clinical Andrology / Centre for Reproductive Medicine and Andrology
University Clinics, Muenster, Germany